Biodesix, Inc.BDSXNASDAQ
Loading
Cost of Revenue Over TimeStable
Percentile Rank71
3Y CAGR+5.7%
5Y CAGR-5.3%
Studio
Year-over-Year Change

Direct costs attributable to producing goods sold

3Y CAGR
+5.7%/yr
vs +33.9%/yr prior
5Y CAGR
-5.3%/yr
Recent acceleration
Acceleration
-28.2pp
Decelerating
Percentile
P71
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
2 yr
Consecutive growthStable
PeriodValueYoY Change
TTM$16.72M+7.4%
2024$15.57M+19.7%
2023$13.01M-8.1%
2022$14.15M-53.6%
2021$30.52M+38.7%
2020$22.00M+262.2%
2019$6.07M+37.9%
2018$4.41M-